{"prompt": "['Trelagliptin-4002', 'Page 60 of 66', 'Version 2.0', 'July 5,2017', 'principal investigator and the chief executive of the study site shall ensure that the auditor has access', 'to all the study-related source documents.', 'CONFIDENTIAL']['Trelagliptin-4002', 'Page 61 of 66', 'Version 2.0', 'July 5,10', '15.0', 'ETHICAL CONDUCT OF CLINICAL STUDY', 'This clinical study shall be conducted with the highest respect for the individual participants (i.e.,', 'study subjects) according to the study protocol, the ethical principles that have their origin in the', 'Declaration of Helsinki, and \"Ethical Guidelines for Medical and Health Research Involving Human', 'Subjects.\" Each principal investigator will conduct the study according to regulatory requirements', 'and in accordance with \"Responsibilities of the Principal Investigator\" in Appendix B.', '15.1', 'Approval of the Ethical Review Board, etc.', 'The Ethical Review Board, etc., shall be constituted in accordance with the regulations.', 'The sponsor or the designee should obtain the document listing the name and title of each committee', 'member. When a committee member directly participates in this clinical study, the document', 'describing that he/she is not participating in deliberation or voting for the study will be obtained.', 'The sponsor or the designee shall supply relevant documents for submission to study site committee', \"such as the Ethical Review Board for the protocol's review and approval. In addition to the study\", 'protocol, a copy of the informed consent form and information sheet, written materials related to', 'study subject recruitment, advertisement, and other documents required by regulations, when', 'necessary, shall be submitted to the central committee or a study site committee such as the Ethical', 'Review Board to obtain approval. The sponsor or the designee must obtain written approval of the', 'protocol and the informed consent form and information sheet from the study site committee such as', 'the Ethical Review Board before commencement of the study. The study site committee such as the', \"Ethical Review Board's approval must refer to the study by exact protocol title, number and version\", 'date; identify versions of other documents (e.g., informed consent form and information sheet)', 'reviewed; and state the approval date. The sponsor shall notify the study site, the principal', 'investigator, and investigator after confirming the validity of the regulatory documents of the study', 'site. Protocol procedures such as obtainment of consent shall not be started until the study site, the', 'principal investigator, and investigator receive notification.', 'The study site shall observe all requirements that the Ethical Review Board, etc. prescribe. The', 'requirements may include notifications to committees such as the Ethical Review Board, for', 'example, revision of the protocol, revision of the informed consent form and information sheet,', 'revision of materials related to study subject recruitment, reports on safety in accordance with the', 'regulatory requirements, reports on status of implementation of the study at intervals determined by', 'a study site committee such as the Ethical Review Board, and submission of the study completion', 'report. The sponsor or the designee shall obtain written approval from the Ethical Review Board, etc.', 'related to the above mentioned items and all related materials.', 'CONFIDENTIAL']['Trelagliptin-4002', 'Page 62 of 66', 'Version 2.0', 'July 5,10', '15.2', 'Conflict of interest', 'This clinical study shall be conducted with the support of the sponsor.', 'Prior to the conduction of this clinical study, the principal investigators involved in this clinical', 'study shall ensure appropriate management of any conflicts of interest (COI) in the conduct of the', 'study in accordance with the rules of the study site.9)-13)', 'The study site shall observe all requirements that the Ethical Review Board, etc. prescribe. This will', 'include self-declaration of COI, clinical study protocol, informed consent form and information', 'sheet.', '15.3', 'Informed consent form and information sheet, and the agreement of the', 'study subjects', 'The informed consent form shall contain specific requirements of the Declaration of Helsinki,', 'Ethical Guidelines for Medical and Health Research Involving Human Subjects and all applicable', 'laws and regulations. The informed consent form and information sheet shall specify the use of', 'personal information and medical information of study subjects in this clinical study (both in and', 'outside Japan: supply to a third party), and disclosure. The informed consent form will explain in', 'detail the nature of the clinical study, its objectives, and potential risks and benefits. The informed', 'consent form will detail the requirements of the participant and the fact that study subject is free to', 'withdraw at any time without giving a reason and without any negative effect on further medical', 'care.', 'The principal investigator is responsible for the preparation, contents, and approval of the informed', 'consent form and information sheet by the committee such as the Ethical Review Board. The', 'informed consent form and information sheet must be approved by the committee such as the Ethical', 'Review Board prior to use.', 'The informed consent form shall be written in language that can be easily understood by the', 'potential study subjects. The principal investigator or investigator shall be responsible for providing', 'detailed explanation of the informed consent form to the potential study subjects. Information should', 'be given in both oral and written form whenever possible and in manner deemed appropriate by the', 'committee such as the Ethical Review Board.', 'Once signed, the original informed consent form shall be retained by the principal investigator or', 'investigator. The principal investigator or investigator shall record the date that the potential study', \"subject signed the informed consent form in the subject's medical record. A copy of the signed\", 'informed consent form shall be given to the study subject.', 'The principal investigator or investigator shall follow the same procedure as for obtaining the initial', 'consent when newly obtaining re-consent from the concerned study subject when the informed', 'CONFIDENTIAL']\n\n###\n\n", "completion": "END"}